Antibody Recognition of a Highly Conserved Influenza Virus Epitope

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Kwong, P. D., Wyatt, R. T., Robinson, J. E., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,963

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution

Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981) · Nature · doi:10.1038/289366a0 · Cited by 2,537

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623

Structure of influenza haemagglutinin at the pH of membrane fusion

Bullough, P. A., Hughson, F. M., Skehel, J. J., & Wiley, D. C. (1994) · Nature · doi:10.1038/371037a0 · Cited by 1,564

An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex

García, K. C., Degano, M., Stanfield, R. L., Brunmark, A. B., Jackson, M. R., Peterson, P. A., Teyton, L., & Wilson, I. A. (1996) · Science · doi:10.1126/science.274.5285.209 · Cited by 1,301

Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus

Stevens, J., Blixt, O., Tumpey, T. M., Taubenberger, J. K., Paulson, J. C., & Wilson, I. A. (2006) · Science · doi:10.1126/science.1124513 · Cited by 941

Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics

Kawaoka, Y., Krauss, S. L., & Webster, R. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4603-4608.1989 · Cited by 809

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

Kiso, M., Mitamura, K., Sakai‐Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N., & Kawaoka, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16934-1 · Cited by 785

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

Throsby, M., van den Brink, E. N., Jongeneelen, M. A. C., Poon, L. L. M., Alard, P., Cornelissen, L. A. H. M., Bakker, A. Q., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 738

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells

Cao, Y., Su, B., Guo, X., Sun, W., Deng, Y., Bao, L., Zhu, Q., Zhang, X., Zheng, Y., Geng, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.025 · Cited by 1,188

FUBAR: A Fast, Unconstrained Bayesian AppRoximation for Inferring Selection

Murrell, B., Moola, S., Mabona, A., Weighill, T., Sheward, D. J., Pond, S. L. K., & Scheffler, K. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst030 · Cited by 1,404

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707304114 · Cited by 1,073

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

Kanekiyo, M., Wei, C., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 887

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

McLellan, J. S., Chen, M., Leung, S., Graepel, K. W., Du, X., Yang, Y., Zhou, T., Baxa, U., Yasuda, E., Beaumont, T., et al. (2013) · Science · doi:10.1126/science.1234914 · Cited by 883

Highly Conserved Protective Epitopes on Influenza B Viruses

Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M. A. C., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 857

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M. A. C., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 820

The human antibody response to influenza A virus infection and vaccination

Krammer, F. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 819

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Wrammert, J., Koutsonanos, D., Li, G., Edupuganti, S., Sui, J., Michael, M., McCausland, M. M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777

Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors

Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770

Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

Yassine, H. M., Boyington, J. C., McTamney, P. M., Wei, C., Kanekiyo, M., Kong, W., Gallagher, J. R., Wang, L., Zhang, Y., Joyce, M. G., et al. (2015) · Nature Medicine · doi:10.1038/nm.3927 · Cited by 700

Antibody Structure and Function: The Basis for Engineering Therapeutics

Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 711

Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins

Gamblin, S. J., & Skehel, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.129809 · Cited by 673

From Vaccines to Memory and Back

Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 659

Design of protein-binding proteins from the target structure alone

Cao, L., Coventry, B., Goreshnik, I., Huang, B., Sheffler, W., Park, J. S., Jude, K. M., Marković, I., Kadam, R. U., Verschueren, K. H. G., et al. (2022) · Nature · doi:10.1038/s41586-022-04654-9 · Cited by 577

Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin

Fleishman, S. J., Whitehead, T. A., Ekiert, D. C., Dreyfus, C., Corn, J. E., Strauch, E.-M., Wilson, I. A., & Baker, D. (2011) · Science · doi:10.1126/science.1202617 · Cited by 585

Peptide-Based Vaccines: Current Progress and Future Challenges

Malonis, R. J., Lai, J. R., & Vergnolle, O. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00472 · Cited by 602

A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen

Impagliazzo, A., Milder, F. J., Kuipers, H., Wagner, M. V., Zhu, X., Hoffman, R. M. B., van Meersbergen, R., Huizingh, J., Wanningen, P., Verspuij, J. W. A., et al. (2015) · Science · doi:10.1126/science.aac7263 · Cited by 591

Advances in the development of influenza virus vaccines

Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 592

Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain

Steel, J., Lowen, A. C., Wang, T. T., Yondola, M. A., Gao, Q., Haye, K., García‐Sastre, A., & Palese, P. (2010) · mBio · doi:10.1128/mbio.00018-10 · Cited by 535

The 2009 A (H1N1) influenza virus pandemic: A review

Girard, M. P., Tam, J. S., Assossou, O. M., & Kiény, M. P. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.031 · Cited by 508

B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study

Haynes, B. F., Kelsoe, G. H., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 481

Cross-neutralization of influenza A viruses mediated by a single antibody loop

Ekiert, D. C., Kashyap, A. K., Steel, J., Rubrum, A. M., Bhabha, G., Khayat, R., Lee, J. H., Dillon, M. A., O’Neil, R. E., Faynboym, A. M., et al. (2012) · Nature · doi:10.1038/nature11414 · Cited by 488

Broadly Neutralizing Antiviral Antibodies

Corti, D., & Lanzavecchia, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095916 · Cited by 469

CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype

Zuccarino-Catania, G., Sadanand, S., Weisel, F. J., Tomayko, M. M., Meng, H., Kleinstein, S. H., Good‐Jacobson, K. L., & Shlomchik, M. J. (2014) · Nature Immunology · doi:10.1038/ni.2914 · Cited by 449

A dynamic T cell–limited checkpoint regulates affinity-dependent B cell entry into the germinal center

Schwickert, T. A., Victora, G. D., Fooksman, D., Kamphorst, A. O., Mugnier, M. R., Gitlin, A. D., Dustin, M. L., & Nussenzweig, M. C. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20102477 · Cited by 427

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., & Gregorio, E. D. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151960 · Cited by 449

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

Corti, D., Suguitan, A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Zatta, F., Santos, C. P., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41902 · Cited by 433

Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol

Kadam, R. U., & Wilson, I. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617020114 · Cited by 443

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes

Kallewaard, N. L., Corti, D., Collins, P. J., Neu, U., McAuliffe, J. M., Benjamin, E., Wachter-Rosati, L., Palmer‐Hill, F. J., Yuan, A. Q., Walker, P. A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.073 · Cited by 410

Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

Krammer, F., Pica, N., Hai, R., Margine, I., & Palese, P. (2013) · Journal of Virology · doi:10.1128/jvi.00641-13 · Cited by 425

Influenza Virus: Dealing with a Drifting and Shifting Pathogen

Kim, H., Webster, R. G., & Webby, R. J. (2018) · Viral Immunology · doi:10.1089/vim.2017.0141 · Cited by 423

Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses

Burton, D. R., Poignard, P., Stanfield, R. L., & Wilson, I. A. (2012) · Science · doi:10.1126/science.1225416 · Cited by 416

Immune history profoundly affects broadly protective B cell responses to influenza

Andrews, S. F., Huang, Y., Kaur, K., Popova, L. I., Ho, I. Y., Pauli, N. T., Henry, C., Taylor, W. M., Lim, S., Huang, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0522 · Cited by 413

Continuing challenges in influenza

Webster, R. G., & Govorkova, E. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12462 · Cited by 413

Hepatitis C Virus E2 Envelope Glycoprotein Core Structure

Kong, L., Giang, E., Nieusma, T., Kadam, R. U., Cogburn, K. E., Hua, Y., Dai, X., Stanfield, R. L., Burton, D. R., Ward, A. B., et al. (2013) · Science · doi:10.1126/science.1243876 · Cited by 407

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

Li, G.-M., Chiu, C., Wrammert, J., McCausland, M. M., Andrews, S. F., Zheng, N., Lee, J.-H., Huang, M., Qu, X., Edupuganti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118979109 · Cited by 393

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

Joyce, M. G., Wheatley, A. K., Thomas, P. V., Chuang, G.-Y., Soto, C., Bailer, R. T., Druz, A., Georgiev, I. S., Gillespie, R. A., Kanekiyo, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.043 · Cited by 333

Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing

Whitehead, T. A., Chevalier, A. A., Song, Y., Dreyfus, C., Fleishman, S. J., de Mattos, C., Myers, C., Kamisetty, H., Blair, P. J., Wilson, I. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2214 · Cited by 367

Learning the language of viral evolution and escape

Hie, B., Zhong, E. D., Berger, B., & Bryson, B. (2021) · Science · doi:10.1126/science.abd7331 · Cited by 361

MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

Khurana, S., Verma, N., Yewdell, J. W., Hilbert, A. K., Castellino, F., Lattanzi, M., Giudice, G. D., Rappuoli, R., & Golding, H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002336 · Cited by 357

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Nachbagauer, R., Feser, J., Naficy, A. B., Bernstein, D. I., Guptill, J. T., Walter, E. B., Berlanda-Scorza, F., Stadlbauer, D., Wilson, P. C., Aydillo, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1118-7 · Cited by 340

Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination

Wei, C., Boyington, J. C., McTamney, P. M., Kong, W., Pearce, M. B., Xu, L., Andersen, H., Rao, S. S., Tumpey, T. M., Yang, Z., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337

Immune responses to influenza virus infection

Kreijtz, J. H. C. M., Fouchier, R. A. M., & Rimmelzwaan, G. F. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.022 · Cited by 335

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico

Robbiani, D. F., Bozzacco, L., Keeffe, J. R., Khouri, R., Olsen, P. C., Gazumyan, A., Schaefer-Babajew, D. J., Ávila‐Ríos, S., Nogueira, L., Patel, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.024 · Cited by 332

Next-generation influenza vaccines: opportunities and challenges

Wei, C., Crank, M. C., Shiver, J. W., Graham, B. S., Mascola, J. R., & Nabel, G. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0056-x · Cited by 324

Structures of influenza A proteins and insights into antiviral drug targets

Das, K., Aramini, J. M., Ma, L.-C., Krug, R. M., & Arnold, E. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1779 · Cited by 330

Influenza virus hemagglutinin stalk-based antibodies and vaccines

Krammer, F., & Palese, P. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.07.007 · Cited by 327

Glycans on influenza hemagglutinin affect receptor binding and immune response

Wang, C.-C., Chen, J.-R., Tseng, Y.-C., Hsu, C.-H., Hung, Y.-F., Chen, S.-W., Chen, C.-M., Khoo, K.-H., Cheng, T.-J., Cheng, Y.-S. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909696106 · Cited by 316

HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure

Kwong, P. D., & Mascola, J. R. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.029 · Cited by 308

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

Kanekiyo, M., Joyce, M. G., Gillespie, R. A., Gallagher, J. R., Andrews, S. F., Yassine, H. M., Wheatley, A. K., Fisher, B. E., Ambrozak, D. R., Creanga, A., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0305-x · Cited by 297

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

Wang, T. T., Tan, G. S., Hai, R., Pica, N., Ngai, L., Ekiert, D. C., Wilson, I. A., García‐Sastre, A., Moran, T. M., & Palese, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013387107 · Cited by 302

Influenza Research Database: an integrated bioinformatics resource for influenza research and surveillance

Squires, R. B., Noronha, J. M., Hunt, V., García‐Sastre, A., Macken, C. A., Baumgarth, N., Suarez, D. L., Pickett, B. E., Zhang, Y., Larsen, C. N., et al. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00331.x · Cited by 297

Rapid development of broadly influenza neutralizing antibodies through redundant mutations

Pappas, L., Foglierini, M., Piccoli, L., Kallewaard, N. L., Turrini, F., Silacci, C., Fernandez-Rodriguez, B. M., Agatic, G., Giacchetto-Sasselli, I., Pellicciotta, G., et al. (2014) · Nature · doi:10.1038/nature13764 · Cited by 290

Toward a Universal Influenza Virus Vaccine: Prospects and Challenges

Pica, N., & Palese, P. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-120611-145115 · Cited by 285

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

Xu, K. Y., Acharya, P., Kong, R., Cheng, C., Chuang, G., Liu, K., Louder, M. K., O'Dell, S. J., Rawi, R., Sastry, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0042-6 · Cited by 278

Ebolavirus Glycoprotein Structure and Mechanism of Entry

Lee, J. E., & Saphire, E. O. (2009) · Future Virology · doi:10.2217/fvl.09.56 · Cited by 281

Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins

Wang, T. T., Tan, G. S., Hai, R., Pica, N., Petersen, E., Moran, T. M., & Palese, P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000796 · Cited by 278

Structural and genetic basis for development of broadly neutralizing influenza antibodies

Lingwood, D., McTamney, P. M., Yassine, H. M., Whittle, J. R. R., Guo, X., Boyington, J. C., Wei, C., & Nabel, G. J. (2012) · Nature · doi:10.1038/nature11371 · Cited by 269

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

Henry Dunand, C. J., Leon, P. E., Huang, M., Choi, A., Chromikova, V., Ho, I. Y., Tan, G. S., Cruz, J., Hirsh, A., Zheng, N.-Y., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.014 · Cited by 268

Adjuvanted influenza vaccines

Tregoning, J. S., Russell, R. F., & Kinnear, E. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1415684 · Cited by 263

Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities

Chiorazzi, N., & Ferrarini, M. (2010) · Blood · doi:10.1182/blood-2010-07-155663 · Cited by 272

Playing Hide and Seek: How Glycosylation of the Influenza Virus Hemagglutinin Can Modulate the Immune Response to Infection

Tate, M. D., Job, E. R., Deng, Y., Gunalan, V., Maurer‐Stroh, S., & Reading, P. C. (2014) · Viruses · doi:10.3390/v6031294 · Cited by 262

From Original Antigenic Sin to the Universal Influenza Virus Vaccine

Henry, C., Palm, A.-K. E., Krammer, F., & Wilson, P. C. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.08.003 · Cited by 262

Convergent Antibody Signatures in Human Dengue

Parameswaran, P., Liu, Y., Roskin, K. M., Jackson, K., Dixit, V. P., Lee, J.-Y., Artiles, K. L., Zompì, S., Vargas, M. J., Simen, B. B., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.008 · Cited by 261

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

Stadlbauer, D., Zhu, X., McMahon, M., Turner, J. S., Wohlbold, T. J., Schmitz, A. J., Strohmeier, S., Yu, W., Nachbagauer, R., Mudd, P. A., et al. (2019) · Science · doi:10.1126/science.aay0678 · Cited by 265

Vaccines: the Fourth Century

Plotkin, S. A. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00290-09 · Cited by 259

Influenza Hemagglutinin Structures and Antibody RecognitionPreprint

Wu, N. C., & Wilson, I. A. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038778 · Cited by 253

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

Pica, N., Hai, R., Krammer, F., Wang, T. T., Maamary, J., Eggink, D., Tan, G. S., Krause, J. C., Moran, T. M., Stein, C. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200039109 · Cited by 251

Broadly neutralizing antibodies target the coronavirus fusion peptide

Dacon, C., Tucker, C., Peng, L., Lee, C.-C. D., Lin, T.-H., Yuan, M., Cong, Y., Wang, L., Purser, L., Williams, J. K., et al. (2022) · Science · doi:10.1126/science.abq3773 · Cited by 250

Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages

Whittle, J. R. R., Wheatley, A. K., Wu, L., Lingwood, D., Kanekiyo, M., Steven, S., Narpala, S., Yassine, H. M., Frank, G. M., Yewdell, J. W., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03422-13 · Cited by 250

Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy

Du, S., Cao, Y., Zhu, Q., Yü, P., Qi, F., Wang, G., Du, X., Bao, L., Deng, W., Zhu, H., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.035 · Cited by 238

Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody

Schmidt, A. G., Xu, H., Khan, A. R., O’Donnell, T. J., Khurana, S., King, L. R., Manischewitz, J. F., Golding, H., Suphaphiphat, P., Carfí, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218256109 · Cited by 247

A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface

Bangaru, S., Lang, S., Schotsaert, M., Vanderven, H. A., Zhu, X., Kose, N., Bombardi, R. G., Finn, J. A., Kent, S. J., Gilchuk, P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.011 · Cited by 255

Functions of Antibodies

Forthal, D. N. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.aid-0019-2014 · Cited by 266

Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses

van de Sandt, C. E., Kreijtz, J. H. C. M., & Rimmelzwaan, G. F. (2012) · Viruses · doi:10.3390/v4091438 · Cited by 267

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

Ellebedy, A. H., Krammer, F., Li, G.-M., Miller, M. S., Chiu, C., Wrammert, J., Chang, C. Y., Davis, C. W., McCausland, M., Elbein, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414070111 · Cited by 234

Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design

Wei, C., Boyington, J. C., Dai, K., Houser, K. V., Pearce, M. B., Kong, W., Yang, Z., Tumpey, T. M., & Nabel, G. J. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000799 · Cited by 232

Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines

Rey, F. A., & Lok, S. (2018) · Cell · doi:10.1016/j.cell.2018.02.054 · Cited by 234

The influenza virus hemagglutinin head evolves faster than the stalk domain

Roubidoux, E. K., Qiu, X., Wilson, P. C., Bahl, J., & Krammer, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-28706-1 · Cited by 231

Advanced Point‐of‐Care Testing Technologies for Human Acute Respiratory Virus Detection

Zhang, Z., Ma, P., Ahmed, R., Wang, J., Akin, D., Soto, F., Liu, B., Li, P., & Demirci, U. (2021) · Advanced Materials · doi:10.1002/adma.202103646 · Cited by 231

Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease

Khurana, S., Loving, C. L., Manischewitz, J. F., King, L. R., Gauger, P. C., Henningson, J. N., Vincent, A. L., & Golding, H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006366 · Cited by 224

Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin

Laursen, N. S., Friesen, R. H. E., Zhu, X., Jongeneelen, M. A. C., Blokland, S., Vermond, J., Real, A. V. E.-O., Tang, C., van Diepen, H. A., Obmolova, G., et al. (2018) · Science · doi:10.1126/science.aaq0620 · Cited by 223

Emerging perspectives in the research of bovine babesiosis and anaplasmosis

Suarez, C. E., & Noh, S. M. (2011) · Veterinary Parasitology · doi:10.1016/j.vetpar.2011.05.032 · Cited by 221

Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope

Correia, B. E., Ban, Y. A., Holmes, M. A., Xu, H., Ellingson, K., Kraft, Z., Carrico, C., Boni, E., Sather, D. N., Zenobia, C., et al. (2010) · Structure · doi:10.1016/j.str.2010.06.010 · Cited by 213

Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines

Lu, Y., Welsh, J. P., & Swartz, J. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308701110 · Cited by 216

Entry of influenza A virus: host factors and antiviral targets

Edinger, T. O., Pohl, M. O., & Stertz, S. (2013) · Journal of General Virology · doi:10.1099/vir.0.059477-0 · Cited by 215

Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies

Jegaskanda, S., Job, E. R., Kramski, M., Laurie, K., Isitman, G., Rose, R. D., Winnall, W. R., Stratov, I., Brööks, A. G., Reading, P. C., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201574 · Cited by 215

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

Bommakanti, G., Citron, M. P., Hepler, R. W., Callahan, C., Heidecker, G. J., Najar, T. A., Lu, X., Joyce, J. G., Shiver, J. W., Casimiro, D. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007465107 · Cited by 214

Antibody responses to viral infections: a structural perspective across three different enveloped viruses

Murin, C. D., Wilson, I. A., & Ward, A. B. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0392-y · Cited by 210

Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus

Lee, P. S., Ohshima, N., Stanfield, R. L., Yu, W., Iba, Y., Okuno, Y., Kurosawa, Y., & Wilson, I. A. (2014) · Nature Communications · doi:10.1038/ncomms4614 · Cited by 211

Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin

Doud, M. B., & Bloom, J. D. (2016) · Viruses · doi:10.3390/v8060155 · Cited by 202

A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin

Krause, J. C., Tsibane, T., Tumpey, T. M., Huffman, C. J., Basler, C. F., & Crowe, J. E. (2011) · Journal of Virology · doi:10.1128/jvi.00700-11 · Cited by 204

Towards a universal influenza vaccine: different approaches for one goal

Sautto, G. A., Kirchenbaum, G. A., & Ross, T. M. (2018) · Virology Journal · doi:10.1186/s12985-017-0918-y · Cited by 202

Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses

Margine, I., Krammer, F., Hai, R., Heaton, N. S., Tan, G. S., Andrews, S., Runstadler, J. A., Wilson, P. C., Albrecht, R. A., García‐Sastre, A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01715-13 · Cited by 197

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection

Mallajosyula, V. V. A., Citron, M. P., Ferrara, F., Lu, X., Callahan, C., Heidecker, G. J., Sarma, S. P., Flynn, J. A., Temperton, N. J., Liang, X., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402766111 · Cited by 191

Influenza Virus-Mediated Membrane Fusion: Determinants of Hemagglutinin Fusogenic Activity and Experimental Approaches for Assessing Virus Fusion

Hamilton, B. S., Whittaker, G. R., & Daniel, S. (2012) · Viruses · doi:10.3390/v4071144 · Cited by 188

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

Ledgerwood, J. E., Wei, C., Hu, Z., Gordon, I. J., Enama, M. E., Hendel, C. S., McTamney, P. M., Pearce, M. B., Yassine, H. M., Boyington, J. C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70240-7 · Cited by 188

A Human Antibody Recognizing a Conserved Epitope of H5 Hemagglutinin Broadly Neutralizes Highly Pathogenic Avian Influenza H5N1 Viruses

Hu, H., Voss, J., Zhang, G., Buchy, P., Zuo, T., Wang, L., Wang, F., Zhou, F., Wang, G., Tsai, C., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06665-11 · Cited by 72

Research highlights

(2009) · Nature Biotechnology · doi:10.1038/nbt0409-348

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M. A. C., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 820

A Virus-Like Particle That Elicits Cross-Reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin

(2016)

An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells

Lee, C., Yang, C.-Y., Lin, L., Ko, T., Chang, A., Chang, S. S.-C., & Wang, A. H. ‐. (2019) · Scientific Reports · doi:10.1038/s41598-019-40937-4 · Cited by 22